Sleep Number Announces Third Quarter 2023 Results

  • Third quarter net sales declined 13% versus the prior year to $473 million; third quarter diluted loss per share of $0.10
  • Initiated approximately $50 million of additional operating expense reduction actions for 2024 on top of an estimated $80 million for 2023
  • Updated 2023 EPS outlook to a loss of up to $0.70 per share, which includes an estimated $10 million or $0.35 per share of restructuring charges to be recorded in the fourth quarter
  • Amended and right-sized bank facility to provide additional covenant flexibility through 2024

MINNEAPOLIS--()--Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended September 30, 2023.

“The third quarter was challenging for Sleep Number and the bedding industry as the consumer demand trajectory changed abruptly midway through the quarter,” said Shelly Ibach, Chair, President and CEO, Sleep Number. “In response, we acted quickly to further reduce costs, recalibrate our sales and marketing approach, and amend our credit agreement to provide additional covenant flexibility through the end of 2024. We expect these actions and broad-based restructuring initiatives to result in a more durable operating model with improved profitability and cash flows in a range of economic environments. We remain confident in our strategic direction and ability to deliver superior value creation over time.”

Third Quarter Financial Overview

  • Net sales decreased 13% to $473 million; demand decelerated abruptly in August and September, leading to a low double-digit demand decline for the quarter versus prior year
  • Gross margin of 57.4% was up 130 bp versus the prior year, primarily benefiting from pricing actions and easing commodity prices
  • Operating expenses were reduced by $25 million to $266 million compared with $290 million last year
  • Loss per diluted share of $0.10 compared with diluted earnings per share of $0.22 last year

Cash Flows Overview

  • Net cash from operating activities of $32 million for the first nine months of the year, compared with $80 million for the same period last year
  • Leverage ratio of 4.8x EBITDAR at the end of the third quarter versus covenant maximum of 5.0x
  • Adjusted ROIC of 14.9% for the trailing twelve months

Business Restructuring Actions

In light of the demand trajectory change in August, the company initiated additional cost reduction actions which are expected to reduce 2024 operating expenses by approximately $50 million, and also accelerated gross margin initiatives. The operating expense reductions are incremental to the $80 million of operating expense reductions we expect to realize in 2023.

  • The cost restructuring actions are broad-based and include a reduction in headcount across all areas of the organization, including in corporate and R&D functions
  • We are rationalizing our store portfolio with a planned closure of 40 to 50 stores by the end of 2024, along with slowing the rate of new store openings and remodels, and also reducing our 2024 capital expenditures
  • Gross margin improvement actions include value engineering and cost optimization strategies, including driving additional efficiencies through our manufacturing and home delivery network
  • The business restructuring actions are expected to result in up to $20 million of one-time restructuring costs, with an estimated $10 million of the costs being recorded in the fourth quarter of this year

Amended Credit Agreement

  • The company also amended the financial covenants of the revolving credit facility to provide greater flexibility through 2024, and right-sized the aggregate availability of the credit facility to $685 million
  • Prospectively, the company will be utilizing a new definition for net leverage as highlighted on page 9 of this news release; our leverage ratio under the new definition was 3.8x EBITDAR at end of the third quarter

Financial Outlook

The company updated its full-year 2023 diluted EPS outlook to a loss of up to $0.70 per share. The updated EPS outlook includes an estimated $10 million, or $0.35 per share, of restructuring charges to be recorded in the fourth quarter. The 2023 outlook assumes net sales are down low double digits versus the prior year, with approximately 100 basis points of gross margin rate improvement year-over-year. The company anticipates 2023 capital expenditures of approximately $60 million.

Conference Call Information

Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EST (4 p.m. CST; 2 p.m. PST) today. To access the webcast, visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days.

About Sleep Number Corporation

Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved over 15 million lives. Our wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our 23 billion hours of longitudinal sleep data and expertise to research with global institutions.

Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our almost 4,500 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in over 650 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number store near you, our newsroom. and investor relations sites, or SleepNumber.com

Forward-looking Statements

Statements used in this news release relating to future plans, events, financial results or performance, such as the company’s full-year 2023 diluted EPS and future capital expenditures and operating expenses, are forward-looking statements subject to certain risks and uncertainties including, among others, such factors as current and future economic conditions and consumer sentiment; ability to realize expected cost savings and other benefits related to cost restructuring actions and to avoid unexpected adverse effects on the company; increases in interest rates, which have increased the cost of servicing the company’s indebtedness; availability of attractive and cost-effective consumer credit options; the effectiveness of the company’s marketing strategy and promotional efforts; the execution of Sleep Number’s Total Retail distribution strategy; operating with minimal levels of inventory, which may leave the company vulnerable to supply shortages; bank failures or other events affecting financial institutions; Sleep Number’s dependence on, and ability to maintain strong working relationships with key suppliers and third parties; rising commodity costs or third-party logistics costs and other inflationary pressures; risks inherent in global-sourcing activities, including tariffs, geo-political turmoil, war, strikes, labor challenges, government-mandated work closures, outbreaks of pandemics or contagious diseases, and resulting supply shortages and production and delivery delays and disruptions; risks of disruption due to health epidemics or pandemics, such as the COVID-19 pandemic; regional risks related to having global operations and suppliers, including climate and other disasters; ability to achieve and maintain high levels of product quality; ability to improve and expand Sleep Number’s product line and execute successful new product introductions; ability to prevent third parties from using the company’s technology or trademarks, and the adequacy of its intellectual property rights to protect its products and brand; ability to compete; risks of disruption in the operation of any of the company’s main manufacturing, distribution, logistics, home delivery, product development or customer service operations; the company’s ability to comply with existing and changing government regulation; pending or unforeseen litigation and the potential for associated adverse publicity; the adequacy of the company’s and third-party information systems and costs and disruptions related to upgrading or maintaining these systems; the company’s ability to withstand cyber threats that could compromise the security of its systems, result in a data breach or business disruption; Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified personnel; the volatility of Sleep Number stock; environmental, social and governance (ESG) risks, including increasing regulation and stakeholder expectations; and the company’s ability to adapt to climate change and readiness for legal or regulatory responses thereto.​ Additional information concerning these and other risks and uncertainties is contained in the company’s filings with the Securities and Exchange Commission (SEC), including the Annual Report on Form 10-K, and other periodic reports filed with the SEC. The company has no obligation to publicly update or revise any of the forward-looking statements in this news release.

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited – in thousands, except per share amounts)

 

 

Three Months Ended

 

September 30,
2023

 

% of
Net Sales

 

October 1,
2022

 

% of
Net Sales

Net sales

$

472,648

 

 

100.0

%

 

$

540,566

 

100.0

%

Cost of sales

 

201,537

 

 

42.6

%

 

 

237,479

 

43.9

%

Gross profit

 

271,111

 

 

57.4

%

 

 

303,087

 

56.1

%

Operating expenses:

 

 

 

 

 

 

 

Sales and marketing

 

221,143

 

 

46.8

%

 

 

239,656

 

44.3

%

General and administrative

 

31,948

 

 

6.8

%

 

 

36,003

 

6.7

%

Research and development

 

12,633

 

 

2.7

%

 

 

14,786

 

2.7

%

Total operating expenses

 

265,724

 

 

56.2

%

 

 

290,445

 

53.7

%

Operating income

 

5,387

 

 

1.1

%

 

 

12,642

 

2.3

%

Interest expense, net

 

10,958

 

 

2.3

%

 

 

5,606

 

1.0

%

(Loss) Income before income taxes

 

(5,571

)

 

(1.2

%)

 

 

7,036

 

1.3

%

Income tax (benefit) expense

 

(3,253

)

 

(0.7

%)

 

 

2,003

 

0.4

%

Net (loss) income

$

(2,318

)

 

(0.5

%)

 

$

5,033

 

0.9

%

 

 

 

 

 

 

 

 

Net (loss) income per share – basic

$

(0.10

)

 

 

 

$

0.23

 

 

 

 

 

 

 

 

 

 

Net (loss) income per share – diluted

$

(0.10

)

 

 

 

$

0.22

 

 

 

 

 

 

 

 

 

 

Reconciliation of weighted-average shares outstanding:

Basic weighted-average shares outstanding

 

22,479

 

 

 

 

 

22,218

 

 

Dilutive effect of stock-based awards

 

 

 

 

 

 

355

 

 

Diluted weighted-average shares outstanding

 

22,479

 

 

 

 

 

22,573

 

 

For the three months ended September 30, 2023, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited – in thousands, except per share amounts)

 

 

Nine Months Ended

 

September 30,
2023

 

% of

Net Sales

 

October 1,
2022

 

% of

Net Sales

Net sales

$

1,457,964

 

100.0

%

 

$

1,616,769

 

100.0

%

Cost of sales

 

612,343

 

42.0

%

 

 

686,439

 

42.5

%

Gross profit

 

845,621

 

58.0

%

 

 

930,330

 

57.5

%

Operating expenses:

 

 

 

 

 

 

 

Sales and marketing

 

649,410

 

44.5

%

 

 

700,405

 

43.3

%

General and administrative

 

111,144

 

7.6

%

 

 

116,049

 

7.2

%

Research and development

 

42,521

 

2.9

%

 

 

46,908

 

2.9

%

Total operating expenses

 

803,075

 

55.1

%

 

 

863,362

 

53.4

%

Operating income

 

42,546

 

2.9

%

 

 

66,968

 

4.1

%

Interest expense, net

 

30,008

 

2.1

%

 

 

11,352

 

0.7

%

Income before income taxes

 

12,538

 

0.9

%

 

 

55,616

 

3.4

%

Income tax expense

 

2,637

 

0.2

%

 

 

13,576

 

0.8

%

Net income

$

9,901

 

0.7

%

 

$

42,040

 

2.6

%

 

 

 

 

 

 

 

 

Net income per share – basic

$

0.44

 

 

 

$

1.87

 

 

 

 

 

 

 

 

 

 

Net income per share – diluted

$

0.44

 

 

 

$

1.83

 

 

 

 

 

 

 

 

 

 

Reconciliation of weighted-average shares outstanding:

Basic weighted-average shares outstanding

 

22,412

 

 

 

 

22,444

 

 

Dilutive effect of stock-based awards

 

146

 

 

 

 

515

 

 

Diluted weighted-average shares outstanding

 

22,558

 

 

 

 

22,959

 

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Balance Sheets

(unaudited – in thousands, except per share amounts)

subject to reclassification

 

 

September 30,
2023

 

December 31,
2022

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

906

 

 

$

1,792

 

Accounts receivable, net of allowances of $1,408 and $1,267, respectively

 

18,631

 

 

 

26,005

 

Inventories

 

116,224

 

 

 

114,034

 

Prepaid expenses

 

21,076

 

 

 

16,006

 

Other current assets

 

41,230

 

 

 

39,921

 

Total current assets

 

198,067

 

 

 

197,758

 

Non-current assets:

 

 

 

Property and equipment, net

 

190,707

 

 

 

200,605

 

Operating lease right-of-use assets

 

401,564

 

 

 

397,755

 

Goodwill and intangible assets, net

 

66,690

 

 

 

68,065

 

Deferred income taxes

 

21,391

 

 

 

7,958

 

Other non-current assets

 

82,616

 

 

 

81,795

 

Total assets

$

961,035

 

 

$

953,936

 

Liabilities and Shareholders’ Deficit

 

 

 

Current liabilities:

 

 

 

Borrowings under revolving credit facility

$

488,000

 

 

$

459,600

 

Accounts payable

 

168,883

 

 

 

176,207

 

Customer prepayments

 

45,902

 

 

 

73,181

 

Accrued sales returns

 

23,012

 

 

 

25,594

 

Compensation and benefits

 

24,281

 

 

 

31,291

 

Taxes and withholding

 

27,198

 

 

 

23,622

 

Operating lease liabilities

 

83,143

 

 

 

79,533

 

Other current liabilities

 

58,907

 

 

 

60,785

 

Total current liabilities

 

919,326

 

 

 

929,813

 

Non-current liabilities:

 

 

 

Operating lease liabilities

 

356,579

 

 

 

356,879

 

Other non-current liabilities

 

105,817

 

 

 

105,421

 

Total non-current liabilities

 

462,396

 

 

 

462,300

 

Total liabilities

 

1,381,722

 

 

 

1,392,113

 

Shareholders’ deficit:

 

 

 

Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding

 

 

 

 

 

Common stock, $0.01 par value; 142,500 shares authorized, 22,228 and 22,014 shares issued and outstanding, respectively

 

222

 

 

 

220

 

Additional paid-in capital

 

12,769

 

 

 

5,182

 

Accumulated deficit

 

(433,678

)

 

 

(443,579

)

Total shareholders’ deficit

 

(420,687

)

 

 

(438,177

)

Total liabilities and shareholders’ deficit

$

961,035

 

 

$

953,936

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(unaudited – in thousands)

subject to reclassification

 

 

Nine Months Ended

 

September 30,
2023

 

October 1,
2022

Cash flows from operating activities:

 

 

 

Net income

$

9,901

 

 

$

42,040

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation and amortization

 

55,196

 

 

 

49,342

 

Stock-based compensation

 

10,872

 

 

 

8,585

 

Net loss on disposals and impairments of assets

 

464

 

 

 

274

 

Deferred income taxes

 

(13,433

)

 

 

(6,955

)

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

7,374

 

 

 

(1,029

)

Inventories

 

(2,190

)

 

 

(11,080

)

Income taxes

 

3,571

 

 

 

4,530

 

Prepaid expenses and other assets

 

(5,903

)

 

 

20,082

 

Accounts payable

 

5,199

 

 

 

28,889

 

Customer prepayments

 

(27,279

)

 

 

(34,225

)

Accrued compensation and benefits

 

(6,923

)

 

 

(23,735

)

Other taxes and withholding

 

5

 

 

 

4,744

 

Other accruals and liabilities

 

(5,038

)

 

 

(1,340

)

Net cash provided by operating activities

 

31,816

 

 

 

80,122

 

 

 

 

 

Cash flows from investing activities:

 

 

 

Purchases of property and equipment

 

(48,022

)

 

 

(52,808

)

Proceeds from sales of property and equipment

 

10

 

 

 

49

 

Issuance of notes receivable

 

(1,317

)

 

 

 

Net cash used in investing activities

 

(49,329

)

 

 

(52,759

)

 

 

 

 

Cash flows from financing activities:

 

 

 

Net increase in short-term borrowings

 

20,334

 

 

 

34,781

 

Repurchases of common stock

 

(3,711

)

 

 

(64,141

)

Proceeds from issuance of common stock

 

428

 

 

 

998

 

Debt issuance costs

 

(424

)

 

 

(42

)

Net cash provided by (used in) financing activities

 

16,627

 

 

 

(28,404

)

 

 

 

 

Net decrease in cash and cash equivalents

 

(886

)

 

 

(1,041

)

Cash and cash equivalents, at beginning of period

 

1,792

 

 

 

2,389

 

Cash and cash equivalents, at end of period

$

906

 

 

$

1,348

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Supplemental Financial Information

(unaudited)

 

 

Three Months Ended

 

Nine Months Ended

 

September 30,
2023

 

October 1,
2022

 

September 30,
2023

 

October 1,
2022

Percent of sales:

 

 

 

 

 

 

 

Retail stores

 

86.6

%

 

 

86.3

%

 

 

87.1

%

 

 

86.7

%

Online, phone, chat and other

 

13.4

%

 

 

13.7

%

 

 

12.9

%

 

 

13.3

%

Total Company

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

 

 

 

 

 

 

Sales change rates:

 

 

 

 

 

 

 

Retail comparable-store sales

 

(14

%)

 

 

(21

%)

 

 

(11

%)

 

 

(10

%)

Online, phone and chat

 

(14

%)

 

 

0

%

 

 

(13

%)

 

 

3

%

Total Retail comparable sales change

 

(14

%)

 

 

(18

%)

 

 

(11

%)

 

 

(8

%)

Net opened/closed stores and other

 

1

%

 

 

2

%

 

 

1

%

 

 

3

%

Total Company

 

(13

%)

 

 

(16

%)

 

 

(10

%)

 

 

(5

%)

 

 

 

 

 

 

 

 

Stores open:

 

 

 

 

 

 

 

Beginning of period

 

672

 

 

 

659

 

 

 

670

 

 

 

648

 

Opened

 

8

 

 

 

12

 

 

 

27

 

 

 

35

 

Closed

 

(2

)

 

 

(9

)

 

 

(19

)

 

 

(21

)

End of period

 

678

 

 

 

662

 

 

 

678

 

 

 

662

 

 

 

 

 

 

 

 

 

Other metrics:

 

 

 

 

 

 

 

Average sales per store ($ in 000's) 1

$

2,952

 

 

$

3,302

 

 

 

 

 

Average sales per square foot 1

$

963

 

 

$

1,093

 

 

 

 

 

Stores > $2 million net sales 2

 

67

%

 

 

77

%

 

 

 

 

Stores > $3 million net sales 2

 

27

%

 

 

38

%

 

 

 

 

Average revenue per smart bed unit 3

$

5,640

 

 

$

5,083

 

 

$

5,822

 

 

$

5,416

 

1 Trailing twelve months Total Retail comparable sales per store open at least one year.
2 Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).
3 Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
(in thousands)

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:

 

Three Months Ended

 

Trailing Twelve Months Ended

 

September 30,
2023

 

October 1,
2022

 

September 30,
2023

 

October 1,
2022

Net (loss) income

$

(2,318

)

 

$

5,033

 

$

4,471

 

$

53,181

Income tax (benefit) expense

 

(3,253

)

 

 

2,003

 

 

1,346

 

 

15,247

Interest expense

 

10,958

 

 

 

5,606

 

 

37,641

 

 

13,196

Depreciation and amortization

 

18,200

 

 

 

17,180

 

 

72,338

 

 

64,217

Stock-based compensation

 

982

 

 

 

542

 

 

15,511

 

 

12,097

Asset impairments

 

292

 

 

 

95

 

 

491

 

 

338

Adjusted EBITDA

$

24,861

 

 

$

30,459

 

$

131,798

 

$

158,276

Free Cash Flow

(in thousands)

 

 

Three Months Ended

 

Trailing Twelve Months Ended

 

September 30,
2023

 

October 1,
2022

 

September 30,
2023

 

October 1,
2022

Net cash provided by (used in) by operating activities

$

13,096

 

 

$

51,431

 

$

(12,168

)

 

$

87,448

Subtract: Purchases of property and equipment

 

18,123

 

 

 

16,249

 

 

64,668

 

 

 

70,338

Free cash flow

$

(5,027

)

 

$

35,182

 

$

(76,836

)

 

$

17,110

Note - Our Adjusted EBITDA calculations and Free Cash Flow data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Net Leverage Ratio under Revolving Credit Facility
(in thousands)

Our calculation of Net Leverage Ratio under Revolving Credit Facility was changed effective with the amendment of our credit facility on November 2, 2023. Prior to the amendment, the calculation included capitalized operating lease obligations based on a multiple of six times annual rent expense. The amendment replaced this line item with operating lease liabilities included in our financial statements under ASC 842. The calculations in accordance with the credit facility prior to, and subsequent to, the November 2, 2023 amendment are presented below:

PRIOR TO AMENDMENT OF OUR CREDIT FACILITY ON NOVEMBER 2, 2023

 

Trailing Twelve Months Ended

 

September 30,
2023

 

October 1,
2022

Borrowings under revolving credit facility

$

488,000

 

$

406,300

Outstanding letters of credit

 

7,147

 

 

5,947

Finance lease obligations

 

338

 

 

450

Consolidated funded indebtedness

$

495,485

 

$

412,697

Capitalized operating lease obligations 1

 

679,224

 

 

650,742

Total debt including capitalized operating lease obligations (a)

$

1,174,709

 

$

1,063,439

 

 

 

 

Adjusted EBITDA (see above)

$

131,798

 

$

158,276

Consolidated rent expense

 

113,204

 

 

108,457

Consolidated EBITDAR (b)

$

245,002

 

$

266,733

Net Leverage Ratio under revolving credit facility (a divided by b)

4.8 to 1.0

 

4.0 to 1.0

1 A multiple of six times annual rent expense is used as an estimate for capitalizing our operating lease obligations in accordance with our credit facility.

SUBSEQUENT TO AMENDMENT OF OUR CREDIT FACILITY ON NOVEMBER 2, 2023

 

Trailing Twelve Months Ended

 

September 30,
2023

 

October 1,
2022

Borrowings under revolving credit facility

$

488,000

 

$

406,300

Outstanding letters of credit

 

7,147

 

 

5,947

Finance lease obligations

 

338

 

 

450

Consolidated funded indebtedness

$

495,485

 

$

412,697

Operating lease liabilities 1

 

439,722

 

 

427,613

Total debt including operating lease liabilities (a)

$

935,207

 

$

840,310

 

 

 

 

Adjusted EBITDA (see above)

$

131,798

 

$

158,276

Consolidated rent expense

 

113,204

 

 

108,457

Consolidated EBITDAR (b)

$

245,002

 

$

266,733

Net Leverage Ratio under revolving credit facility (a divided by b)

3.8 to 1.0

 

3.2 to 1.0

1 Reflects operating lease liabilities included in our financial statements under ASC 842.

Note - Our Net Leverage Ratio under Revolving Credit Facility, EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Return on Invested Capital (Adjusted ROIC)
(in thousands)

Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

 

Trailing Twelve Months Ended

 

September 30,
2023

 

October 1,
2022

Adjusted net operating profit after taxes (Adjusted NOPAT)

 

 

 

Operating income

$

43,458

 

 

$

81,625

 

Add: Operating lease interest 1

 

27,497

 

 

 

25,419

 

Less: Income taxes 2

 

(1,168

)

 

 

(24,306

)

Adjusted NOPAT

$

69,787

 

 

$

82,738

 

 

 

 

 

Average adjusted invested capital

 

 

 

Total deficit

$

(420,687

)

 

$

(437,471

)

Add: Long-term debt 3

 

488,338

 

 

 

406,750

 

Add: Operating lease liabilities 4

 

439,722

 

 

 

427,613

 

Total adjusted invested capital at end of period

$

507,373

 

 

$

396,892

 

 

 

 

 

Average adjusted invested capital 5

$

469,782

 

 

$

371,674

 

 

 

 

 

Adjusted ROIC 6

 

14.9

%

 

 

22.3

%

1

Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases.

2

Reflects annual effective income tax rates, before discrete adjustments, of 1.6% and 22.7% for September 30, 2023 and October 1, 2022, respectively.

3

Long-term debt includes existing finance lease liabilities.

4

Reflects operating lease liabilities included in our financial statements under ASC 842.

5

Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.

6

Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.

 

 

 

Note - the Company's adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. The Company updated its Adjusted ROIC calculation effective beginning with the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842. The prior period has been updated to reflect this calculation.

 

GAAP - generally accepted accounting principles in the U.S.

 

 

Contacts

Investor Contact: Dave Schwantes; (763) 551-7498; investorrelations@sleepnumber.com
Media Contact: Julie Elepano; julie.elepano@sleepnumber.com

Contacts

Investor Contact: Dave Schwantes; (763) 551-7498; investorrelations@sleepnumber.com
Media Contact: Julie Elepano; julie.elepano@sleepnumber.com